You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

Diatrizoate meglumine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for diatrizoate meglumine and what is the scope of freedom to operate?

Diatrizoate meglumine is the generic ingredient in thirty-two branded drugs marketed by Bayer Hlthcare, Bracco, Ge Healthcare, Intl Medication, Mallinckrodt, Liebel-flarsheim, Anda Repository, and Annora Pharma, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for diatrizoate meglumine. One supplier is listed for this compound.

Summary for diatrizoate meglumine
Recent Clinical Trials for diatrizoate meglumine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lawson Health Research InstitutePhase 4

See all diatrizoate meglumine clinical trials

Pharmacology for diatrizoate meglumine
Medical Subject Heading (MeSH) Categories for diatrizoate meglumine

US Patents and Regulatory Information for diatrizoate meglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare HYPAQUE diatrizoate meglumine INJECTABLE;INJECTION 016403-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mallinckrodt MD-76 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 087073-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mallinckrodt MD-60 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 087074-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Liebel-flarsheim MD-76R diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 019292-001 Sep 29, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare ANGIOVIST 292 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 087724-001 Sep 23, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bracco RENO-60 diatrizoate meglumine INJECTABLE;INJECTION 010040-016 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bracco RENO-DIP diatrizoate meglumine INJECTABLE;INJECTION 010040-012 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.